Abyntek Research Reagents was established in 2021, with a dual purpose. On the one hand, to provide the scientific community with a wide range of high quality bioreagents for cancer research and, on the other hand, to contribute to breast cancer research by donating a portion of our profits to this cause.
In our spirit of contributing to excellence in the supply of reagents for research, we have launched a battery of high quality bioreagents for cancer research, including more than 46,000 references of antibodies, proteins and ELISA/ CLIA kits for the study of hundreds of biomarkers of different types of cancer.
Nowadays, Abyntek Research Reagents has rebranded as ABYLABEL, a company that upholds the same standards of quality and social responsibility. The new brand expands its product line to include reagents targeting biomarkers, with applications in various research fields, including:
- Cancer
- Cardiovascular
- Digestive System
- Hematology
- Respiratory system
- Renal function
- Neuroscience
- Dermatology
- Hepatocellular
- Systemic
- Nutrition
- Reproductive biology
- Hormonal metabolism
- Bone structure and metabolism
- Cell growth and differentiation
